About Centro de Pesquisa e Ensino em Oncologia de Santa Catarina - CEPEN
Clinical Trials at Centro de Pesquisa e Ensino em Oncologia de Santa Catarina - CEPEN
During the past decade, Centro de Pesquisa e Ensino em Oncologia de Santa Catarina - CEPEN conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Pesquisa e Ensino em Oncologia de Santa Catarina - CEPEN"
#1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Pharmacyclics LLC." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Centro de Pesquisa e Ensino em Oncologia de Santa Catarina - CEPEN
According to Clinical.Site data, the most researched conditions in "Centro de Pesquisa e Ensino em Oncologia de Santa Catarina - CEPEN" are
"Carcinoma, Non-Small-Cell Lung" (1 trials), "First Line Non-Small Cell Lung Cancer" (1 trials), "Lung Cancer" (1 trials), "Lymphoma, Mantle-Cell" (1 trials) and "Melanoma" (1 trials). Many other conditions were trialed in "Centro de Pesquisa e Ensino em Oncologia de Santa Catarina - CEPEN" in a lesser frequency.
Clinical Trials Intervention Types at Centro de Pesquisa e Ensino em Oncologia de Santa Catarina - CEPEN
Most popular intervention types in "Centro de Pesquisa e Ensino em Oncologia de Santa Catarina - CEPEN" are "Drug" (8 trials). Other intervention types were less common.
The name of intervention was led by "Avelumab" (2 trials), "Bortezomib" (2 trials), "Carboplatin" (2 trials), "Daratumumab" (2 trials) and "Dexamethasone" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Centro de Pesquisa e Ensino em Oncologia de Santa Catarina - CEPEN
The vast majority of trials in "Centro de Pesquisa e Ensino em Oncologia de Santa Catarina - CEPEN" are
7 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Centro de Pesquisa e Ensino em Oncologia de Santa Catarina - CEPEN
Currently, there are NaN active trials in "Centro de Pesquisa e Ensino em Oncologia de Santa Catarina - CEPEN".
undefined are not yet recruiting,
6 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Centro de Pesquisa e Ensino em Oncologia de Santa Catarina - CEPEN,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centro de Pesquisa e Ensino em Oncologia de Santa Catarina - CEPEN, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".